Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients.
María Martin-VicenteRaquel AlmansaIsidoro MartínezAna P TedimElena BustamanteLuis TamayoCésar AldecoaJosé Manuel GómezGloria RenedoJose Ángel BerezoJamil Antonio CedeñoNuria MamolarPablo García OlivaresRubén Herrán-MongeRamón CicuendezPedro EnríquezAlicia OrtegaNoelia JorgeCristina DoncelAmanda de la FuenteJuan Bustamante-MunguiraMaría José Muñoz-GómezMilagros González-RiveraCarolina PuertasVicente MásMónica VázquezFelipe Pérez-GarcíaJesús Rico-FeijooSilvia MartínAnna MotosLaia Fernandez-BaratJose María EirosMarta Dominguez-GilRicard FerrerFerrán BarbéWysali TrapielloDavid J KelvinJesús F Bermejo-MartinSalvador Resino GarcíaAntoni TorresPublished in: Journal of internal medicine (2021)
Low anti-SARS-CoV-2 S antibody levels predict mortality in critical COVID-19. Our findings support that these antibodies contribute to prevent systemic dissemination of SARS-CoV-2.